Related Experiment Video
Updated: Jan 10, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
Published on: November 4, 2018
Neonatal Pyruvate Kinase Deficiency Presenting with Severe Hemolytic Anemia and Liver Failure
Yung-Han Hsu1, Chuen-Bin Jiang2,3, Jen-Yin Hou4
1Department of Pediatrics, Hsinchu Municipal MacKay Children's Hospital, Hsinchu City 300046, Taiwan.
Pyruvate kinase deficiency (PKD) can cause severe neonatal liver failure, not just anemia. Early genetic testing is crucial for managing this rare but serious condition in newborns.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Pyruvate kinase deficiency (PKD) is a common glycolytic enzyme defect.
- It typically causes chronic non-spherocytic hemolytic anemia.
- Severe neonatal liver failure is a rare presentation of PKD.
Related Concept Videos
Inborn Errors of Metabolism
Pyruvate Oxidation
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Fates of Pyruvate
In aerobic organisms, pyruvate is metabolized via the citric acid cycle to produce reduced coenzymes NADH and FADH2. These coenzymes are then oxidized in the electron transport chain to produce ATP and, in the process, regenerate the NAD+ and FAD. As seen in some cell types and organisms, fermentation...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

